M&G plc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
183,973
-819,277
-82% -$9.8M 0.01% 286
2026
Q1
$6.02M Buy
1,003,250
+10,938
+1% +$82.3K 0.03% 258
2025
Q4
$6.95M Buy
992,312
+49,482
+5% +$391K 0.04% 247
2025
Q3
$10.4M Buy
942,830
+75,196
+9% +$738K 0.06% 210
2025
Q2
$8.68M Buy
867,634
+496,362
+134% +$5.12M 0.05% 227
2025
Q1
$5.57M Buy
371,272
+98,956
+36% +$1.52M 0.03% 269
2024
Q4
$4.08M Buy
272,316
+68,154
+33% +$1.11M 0.03% 291
2024
Q3
$3.88M Buy
204,162
+8,514
+4% +$176K 0.01% 290
2024
Q2
$4.11M Buy
195,648
+26,092
+15% +$519K 0.02% 276
2024
Q1
$3.22M Buy
+169,556
New +$2.91M 0.01% 314

Other funds holding OGN

M&G plc's OGN Position: Q2 2026 in Review

M&G plc reduced its Organon & Co (OGN) stake by 82% in Q2 2026, selling an estimated $9.8M and leaving 183,973 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #286.

M&G plc first reported a position in OGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.4M in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • M&G plc held 183,973 shares of Organon & Co worth $2.58M as of Q2 2026.
  • M&G plc sold 819,277 Organon & Co shares in Q2 2026, an estimated $9.8M.
  • Organon & Co made up 0.01% of M&G plc's portfolio in Q2 2026, its #286 holding.
  • M&G plc first reported a position in Organon & Co in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Organon & Co position peaked at $10.4M in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.